Tag Archives: biotechnology investment

NYC Launches $100M Life Science Fund

Deputy-Mayor-Robert-Steel-115x76

On Tuesday, Deputy Mayor Robert Steel announced that the city is launching the New York City Emerging Life Science Technology Investment Fund, a $100 million venture fund for life sciences research. New York City will invest $10 million along with $40 million from Eli Lilly, Celgene and GE Ventures, with the remaining $50 million matched by venture capital partnerships. The fund will be used to invest in 15-20 early-stage research and development companies by 2020. Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

David Thomas

With 31 (and counting) life sciences companies having already placed IPOs on the market within the first 8 months of this year and many others lining up for S-1 filings, biotech is buzzing about a revival of the IPO market. Is it a bubble? David Thomas, director of Industry Research and Analysis at BIO took up these questions during the opening plenary lunch of the 12th Annual BIO Investor Forum. What’s his short answer? Not Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Scientific American Worldview Scorecard Correlates with International Investment

MikeMay

Biotechnology innovation requires investment, and the Scientific American Worldview Scorecard can predict where investment goes. A recent analysis indicates that the ranking of countries in this Scorecard correlates with global investment. As a result, the Worldview Scorecard provides a valuable tool for any country interested in increasing its appeal to biotechnology investors. In short, the Worldview Scorecard uses a wide collection of data – compiled and analyzed by Yali Friedman – that generates a metric Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

It Takes a Village: The New Pharma-VC Model for Biotech Investing

bif-hall

High-profile funding collaborations between pharmaceutical companies and traditional venture capital funds have made headlines in recent months, pooling resources and expertise in an attempt to source and develop the most successful drugs. BIO Executive Vice President Alan Eisenberg moderated It Takes a Village: The New Pharma-VC Model for Biotech Investing, a panel discussion about these new funding models, during the opening plenary session at the 2012 BIO Investor Forum. In the past, venture capital could Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Finding Value in Early Stage Collaborations at the BIO Technology Transfer Symposium

Bridge

The BIO Technology Transfer Symposium dissects recent academia-industry collaborations and evaluates the value in early stage biotechnology investments.  The event occurs in San Francisco on October 8th ahead of the BIO Investor Forum and provides a unique opportunity for bringing academia, industry, and the investment community together. This year’s event is headlined by Tom Thornton from the Cleveland Clinic, a leading academic medical center.  The first panel highlights the collaboration between Duke Translational Research Institute Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,